The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMEL.L Regulatory News (MEL)

  • There is currently no data for MEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Completion Date of Investigation

22 Apr 2022 07:55

RNS Number : 0331J
Mitsubishi Electric Corporation
22 April 2022
 

 

 

 

FOR IMMEDIATE RELEASE

No. 3513

 

 

 

Media Inquiries

 

Takeyoshi Komatsu

 

Public Relations Division

 

Mitsubishi Electric Corporation

 

Tel: +81-3-3218-2346

 

prd.gnews@nk.MitsubishiElectric.co.jp

 

www.MitsubishiElectric.com/news/

 

Notice Regarding Completion Date of the Investigation into

Improper Quality Control Practices

 

TOKYO, April, 21, 2022 - Mitsubishi Electric Corporation (TOKYO: 6503) - Mitsubishi Electric Corporation established the Investigative Committee of external experts (Chaired by Hiroshi Kimeda, Partner (Attorney-at-law), Nishimura & Asahi, previously announced on July 2, 2021) to investigate the facts surrounding the improper quality control practices, elucidate the causes, and formulate measures for preventing any recurrence. The investigation is currently underway at all of the company's manufacturing sites and plants (all 22 facilities).

 

The company had previously announced that the Investigative Committee aimed to complete the investigation of all 22 facilities by April 2022. However, the company was informed today by the Investigative Committee that the committee will require more time to complete the investigation. The company was also informed that the committee expects to complete about 80% or more of the investigation as of end of April and the company will also expect to receive an updated report in late May. The results of the investigation on the remaining facilities will be announced as soon as the reports by the committee are received by the company.

 

Mitsubishi Electric will continue to fully cooperate with the committee's ongoing investigation and will make every effort to uncover the full extent of the improper quality control practices.

 

The Governance Review Committee will separately assess and identify problems relating to the company's internal control system and governance. The committee will aim to provide a summary of issues identified and make recommendations for improvement based on findings by the Investigative Committee.

 

###

 

About Mitsubishi Electric Corporation

With 100 years of experience in providing reliable, high-quality products, Mitsubishi Electric Corporation (TOKYO: 6503) is a recognized world leader in the manufacture, marketing and sales of electrical and electronic equipment used in information processing and communications, space development and satellite communications, consumer electronics, industrial technology, energy, transportation and building equipment. Mitsubishi Electric enriches society with technology in the spirit of its "Changes for the Better." The company recorded a revenue of 4,191.4 billion yen (U.S.$ 37.8 billion*) in the fiscal year ended March 31, 2021. For more information, please visit www.MitsubishiElectric.com

*U.S. dollar amounts are translated from yen at the rate of \111=U.S.$1, the approximate rate on the Tokyo Foreign Exchange Market on March 31, 2021 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKBBQABKKOQB
Date   Source Headline
16th Jan 20237:00 amRNSStatement re (JIS Q 9100/ ISO9001)
28th Dec 20227:00 amRNSStatement re (Change in Oversight of IR and SR)
28th Dec 20227:00 amRNSStatement re (power generator systems business)
19th Dec 20229:17 amRNSStatement re (Delist Shares on LSE)
5th Dec 20229:41 amRNSStatement re IATF16949 Certifications Withdrawal
28th Oct 20227:00 amRNSHalf-year Report
27th Oct 20229:33 amRNSStatement re (Improper quality control practices)
14th Oct 20228:21 amRNSStatement re (Reobtained ISO9001, Nagasaki Works)
22nd Sep 202211:20 amRNSDividend Declaration
20th Sep 20228:41 amRNSStatement re (Reobtained ISO 9001)
30th Aug 20227:00 amRNSStatement re (ISO9001 of Kobe Works etc.)
5th Aug 20227:12 amRNSStatement re (Nagoya Works ISO)
5th Aug 20227:09 amRNSStatement re (Himeji and Sanda Works IATF16949)
28th Jul 20227:00 amRNS1st Quarter Results
27th Jul 202210:52 amRNSStatement re (ISO9001 of Itami Works)
8th Jul 202210:15 amRNSStatement re (ISO9001 of T&D systems center)
8th Jul 202210:08 amRNSStatement re (Kamakura Works ISO9001)
7th Jul 20228:03 amRNSStatement re (ISO9001 of T&D systems center)
4th Jul 20227:00 amRNSStatement re (Rescinded ISO9001 Suspension)
22nd Jun 20228:47 amRNSStatement re (ISO9001 Temporarily Suspended )
16th Jun 202210:01 amRNSStatement re (ISO9001, IRIS Temporarily Suspended)
10th Jun 202210:01 amRNSStatement re (ISO9001 Suspension to be Rescinded)
1st Jun 202210:01 amRNSStatement re (Improper QC Practices Investigation)
1st Jun 202210:00 amRNSStatement re (Compensation Scheme)
25th May 20228:34 amRNSStatement re (Director Candidates)
25th May 20228:27 amRNSDividend Declaration
6th May 20227:25 amRNSStatement re (ISO & IRIS Temporarily Suspended)
28th Apr 20227:00 amRNSFinal Results
22nd Apr 20227:55 amRNSStatement re Completion Date of Investigation
22nd Apr 20227:53 amRNSStatement re Improper Quality Control Practices
1st Apr 20227:00 amRNSStatement re (Director Candidates)
25th Mar 20227:08 amRNSDividend Declaration
11th Mar 20227:00 amRNSStatement re (Rescinded ISO 9001 Suspension)
9th Mar 20227:00 amRNSStatement re (Conclusion of Stock Repurchase)
3rd Mar 20227:00 amRNSStatement re (Company Stock Repurchase)
17th Feb 20227:24 amRNSStatement re (New Building System Subsidiary)
17th Feb 20227:19 amRNSStatement re (New Management Structure)
4th Feb 20227:00 amRNSStatement re (Status of Company Stock Repurchase)
2nd Feb 20227:00 amRNS3rd Quarter Results
26th Jan 20229:22 amRNSStatement re (Rescinded ISO 9001 Suspension)
14th Jan 20228:09 amRNSStatement re (Suspended ISO9001 Certifications)
7th Jan 20227:00 amRNSStatement re (Rescinded ISO 9001 Suspension)
7th Jan 20227:00 amRNSStatement re (Status of Company Stock Repurchase)
24th Dec 20217:00 amRNSStatement re (Improper QC Practice Investigation)
23rd Dec 20217:00 amRNSStatement re (Executive Officer’s Duties Change)
23rd Dec 20217:00 amRNSStatement re (Disciplinary Actions)
23rd Dec 20217:00 amRNSStatement re (Governance Review Committee Report)
23rd Dec 20217:00 amRNSStatement re (Improper QC Investigation Results)
23rd Dec 20217:00 amRNSStatement re (Investigation into Improper QC)
3rd Dec 20217:00 amRNSStatement re (Status of Company Stock Repurchase)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.